| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $53.2M | -17.2% |
| SG&A Expense | $21.4M | +24.5% |
| Operating Income | -$74.6M | +8.4% |
| Pre-tax Income | -$69.6M | +7.8% |
| Income Tax | $55K | -1.8% |
| Net Income | -$69.6M | +7.8% |
| EPS (Basic) | -$2.44 | +15.0% |
| EPS (Diluted) | -$2.44 | +15.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.8M | +43.7% |
| Short-term Investments | $44.9M | -54.7% |
| Current Assets | $80.1M | -35.5% |
| Total Assets | $80.3M | -37.0% |
| Current Liabilities | $3.8M | -78.3% |
| Total Liabilities | $3.9M | -78.3% |
| Stockholders' Equity | $76.4M | -30.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$71.2M | -25.4% |
| Capital Expenditures | $142K | +0.0% |
| Investing Cash Flow | $56.0M | +371.8% |
| Financing Cash Flow | $25.4M | -44.7% |
| Free Cash Flow | -$71.3M | -25.3% |